Platelet-derived lysophosphatidic acid mediated LPAR1 activation as a therapeutic target for osteosarcoma metastasisSatoshi Takagi, Ryohei Katayama, Naoya Fujita et al.|Oncogene|2021Cited by 48
Targeting Podoplanin for the Treatment of OsteosarcomaAi Takemoto, Naoya Fujita, Satoshi Takagi et al.|Clinical Cancer Research|2022Cited by 29
New Systematic Evaluation Method for Attenuated Phase-Shifting Mask SpecificationsIchiro Kagami, Tohru Ogawa, Minoru Sugawara et al.|Japanese Journal of Applied Physics|1995Cited by 2
Supplementary Figure from Targeting Podoplanin for the Treatment of OsteosarcomaAi Takemoto, Naoya Fujita, Satoshi Takagi et al.|Unknown|2023Cited by 0
Data from Targeting Podoplanin for the Treatment of OsteosarcomaAi Takemoto, Naoya Fujita, Satoshi Takagi et al.|Unknown|2023Cited by 0